Biohub secures multi-party investment to advance AI virtual cell and cell behavior prediction projects
Understand the story
On October 7, 2026, The Verge and Reuters reported that Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs jointly invested $300 million in Biohub, a nonprofit biomedical research institution founded by the Zuckerberg couple, for a virtual cell project. The reports did not mention a specific project timeline or how the funds would be allocated. On October 8, The Decoder reported that Biohub, funded by Zuckerberg and Priscilla Chan, is leading an $1.8 billion program to train AI models that can predict cell behavior in order to accelerate drug development, of which $500 million comes from their five-year Virtual Biology Initiative pledged this April. Neither report clarified the specific relationship between the $300 million investment and the $1.8 billion program. So far, only the above two reports exist on this event; the two reports cite different amounts but contain no direct contradictions, and no further updates on other details have emerged.
AI overview of reporting · Updated 11 days ago
Reporting timeline
Explore different aspects of the story through its reporting.
- The DecoderZuckerberg's Biohub leads a $1.8 billion push to build AI models that predict cell behavior
Biohub, the nonprofit funded by Zuckerberg and Priscilla Chan, is leading a $1.8 billion effort to train AI models that predict cell behavior to speed up drug development, including $500 million from the five-year Virtual Biology Initiative they pledged this April.
- The Verge · AIGoogle invests millions in Mark Zuckerberg’s efforts to create a ‘virtual cell’
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million in Biohub, the nonprofit biomedical research organization founded by the Zuckerbergs, according to Reuters.